NCT00284414 is a NA clinical trial of Ultrasonography or MRI in Morton Neuroma, sponsored by University Hospital, Ghent.

Who is sponsoring NCT00284414?

NCT00284414 is sponsored by University Hospital, Ghent.

What drugs are being tested in NCT00284414?

Interventions in NCT00284414: Ultrasonography or MRI.

What condition does NCT00284414 study?

NCT00284414 studies Morton Neuroma.

Is NCT00284414 still recruiting?

NCT00284414 is currently withdrawn. Last updated 2 July 2021.

Last reviewed 2021-07-02 · How we verify

NCT00284414

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is Ultrasonography Comparable to MRI for the Detection of Morton Neuroma of the Foot?

Withdrawn NA Last updated 2 July 2021

What this trial tests

NA trial testing Ultrasonography or MRI in Morton Neuroma. Withdrawn.

Quick facts

Lead sponsor	University Hospital, Ghent
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment

Drugs / interventions tested

Ultrasonography or MRI

Conditions studied

Morton Neuroma — all drugs for Morton Neuroma →

Sponsor

University Hospital, Ghent

Who can join

Adults 20 to 80, any sex, with Morton Neuroma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with Morton neuroma of the foot will undergo either ultrasonography or MRI. The results will be compared. In case of surgery, the pathology report will be compared with the ultrasonographic or MRI findings. Which is the most reliable and specific: ultrasonography or MRI?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Morton Neuroma

Currently open trials in the same condition.

NCT05501262 — Comparative Effectiveness of Cryoablation Versus Steroid and Lidocaine Alone for Treatment of Morton's Neuroma · NA · recruiting

Other University Hospital, Ghent trials

Trials by the same sponsor.

NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00284414 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
Last refreshed: 2 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00284414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing